Category: Finance
-
Infographic – Machine Learning Grabs Most A.I. Investments
So far this year, machine learning applications and platforms are gaining the most investment dollars worldwide for A.I., this weekend’s infographic.
-
Start-Up to Use Crispr for Heart Disease, Gains $59M
A new biotechnology enterprise plans to apply genetic analysis and the gene-editing technology Crispr to reduce the risk of coronary artery disease.
-
Small Business Grant Funds Diabetes Rescue Device
A device to rescue people with diabetes experiencing low blood sugar is being developed by an Indiana company and Purdue University pharmacy lab.
-
Infographic – Venture Deals Cool Off in Q1 2019
Venture capital investments worldwide declined in the first quarter of 2019, compared to the near record-setting pace of the last 3 months of 2018.
-
Radiation-Antibody Biotech Raises $105M in Venture Funds
A company creating cancer treatments that combine radiation therapy with the targeting of synthetic antibodies is raising $105 million in its second round of venture financing.
-
Federal Agency Holds A.I.-Health Outcomes Challenge
The U.S. agency directing Medicare and Medicaid is sponsoring a challenge competition to spur development of artificial intelligence to predict health care outcomes.
-
Genome Editing Biotech Raises $126M in IPO
A biotechnology company developing treatments for disease and enhanced agricultural products with genome editing is raising $126 million in its initial public offering, or IPO, of common stock.
-
Respiratory Vaccine Maker Raises $3.4M in Seed Funds
A company developing vaccines that protect against respiratory diseases in vulnerable populations is raising new seed funds to advance its lead product into clinical trials.
-
App Created for New, Pregnant Moms in Opioid Recovery
A smartphone app is being developed to help pregnant women and new mothers with an opioid addiction, by a medical professor and health care technology company.
-
NSF Funding Natural Agri-Chemical Technology
A start-up company spun-off from Cornell University is receiving a small business grant to develop in crop plants a natural protection against pathogens.